Literature DB >> 18641545

Sensitivity and specificity of urinary cannabinoid detection with two immunoassays after controlled oral administration of cannabinoids to humans.

Sandra B Grauwiler1, Jürgen Drewe, André Scholer.   

Abstract

For forensic and clinical toxicologic purposes, cannabis consumption is screened using easy-to-handle immunoassays. The sensitivity and specificity of these immunoassays have not yet been established in samples from volunteers receiving oral synthetic tetrahydrocannabinol or cannabis extracts using liquid chromatography-mass spectrometry/mass spectrometry as the reference method. Urine samples were collected in an open, randomized, single-center, three-period crossover study including 18 healthy male volunteers given either 20 mg synthetic tetrahydrocannabinol (Marinol) as a control substance or five different types of Cannabis sativa extracts.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18641545     DOI: 10.1097/FTD.0b013e318180c7c2

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  3 in total

1.  Cannabinoid concentrations in confiscated cannabis samples and in whole blood and urine after smoking CBD-rich cannabis as a "tobacco substitute".

Authors:  Marianne Hädener; Tim J Gelmi; Marie Martin-Fabritius; Wolfgang Weinmann; Matthias Pfäffli
Journal:  Int J Legal Med       Date:  2019-01-05       Impact factor: 2.686

Review 2.  Safety and Sourcing of Topical Cannabinoids: Many Questions, Few Answers.

Authors:  Payal M Patel; Peter A Lio
Journal:  J Clin Aesthet Dermatol       Date:  2021-08-01

3.  Is the Urine Cannabinoid Level Measured via a Commercial Point-of-Care Semiquantitative Immunoassay a Cannabis Withdrawal Syndrome Severity Predictor?

Authors:  Benedikt Bernd Claus; Michael Specka; Heath McAnally; Norbert Scherbaum; Fabrizio Schifano; Udo Bonnet
Journal:  Front Psychiatry       Date:  2020-12-03       Impact factor: 4.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.